Leukemia
📧 Sign up to get email alerts when something new happens for Leukemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2019-11-04Clinical Trial Update: Mycophenolate Mofetil, Tacrolimus, Daclizumab, and Donor Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer [Phase 2]
Phase 2 clinical trial investigating mycophenolate mofetil, tacrolimus, daclizumab, and donor peripheral stem cell transplantation for hemat…
-
CLINICAL_TRIALS trial_result · 2019-10-17Clinical Trial Update: Bone Marrow Transplantation in Treating Patients With Hematologic Cancer [Phase 4]
Phase 4 clinical trial update on bone marrow transplantation for hematologic cancers, including conditions such as anemia and graft-versus-h…
-
CLINICAL_TRIALS trial_result · 2019-10-17Clinical Trial Update: Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer [Phase 2]
Phase 2 clinical trial update on peripheral stem cell transplantation for hematologic cancers.
-
CLINICAL_TRIALS trial_result · 2019-10-17Clinical Trial Update: Bevacizumab, Cytarabine, and Mitoxantrone on Treating Patients With Hematologic Cancers [Phase 2]
Phase 2 trial evaluating bevacizumab in combination with cytarabine and mitoxantrone for hematologic cancers has completed.
-
CLINICAL_TRIALS trial_result · 2019-10-15Clinical Trial Update: A Study of Bone Marrow Transplantation Using Fully-Matched Relatives as Donors for Patients With Hematological Malignancies [Phase 2]
Phase 2 study evaluating bone marrow transplantation from fully matched relatives as donors for hematologic malignancies has completed; resu…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2019-09-17Clinical Trial Update: Total-Body Irradiation, Fludarabine, and Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer [Phase 2]
Phase 2 trial evaluating total-body irradiation with fludarabine and peripheral stem cell transplantation in patients with hematologic cance…
-
CLINICAL_TRIALS trial_result · 2019-09-06Clinical Trial Update: Phase l/II Study of Ruxolitinib for Acute Leukemia [Phase 1, Phase 2]
A Phase I/II study of ruxolitinib in acute leukemia was terminated, and trial results have been posted.
-
CLINICAL_TRIALS trial_result · 2019-08-22Clinical Trial Update: A Phase I Study of NK Cell Infusion Following Allogeneic Peripheral Blood Stem Cell Transplantation From Related or Matched Unrelated Donors in Pediatric Patients With Solid Tumors and Leukemias [Phase 1]
Phase I study evaluating NK cell infusions after allogeneic stem cell transplantation in pediatric leukemia and lymphoma patients has comple…
-
CLINICAL_TRIALS trial_result · 2019-08-20Clinical Trial Update: Cladribine in Combination With CAG in Patients With Refractory/Relapsed Acute Myeloid Leukemia [Phase 2]
Phase 2 trial evaluating a cladribine-based combination (CAG) in patients with refractory/relapsed acute myeloid leukemia; status is current…
-
CLINICAL_TRIALS trial_result · 2019-08-07Clinical Trial Update: XLCART001 Treatment in Relapsed/Refractory/High-risk B-cell Malignancy Subjects [Phase 2]
A Phase 2 clinical trial update for XLCART001 in relapsed/refractory/high-risk B-cell malignancies is underway, with status currently UNKNOW…
-
CLINICAL_TRIALS trial_result · 2019-08-06Clinical Trial Update: Trial of Sirolimus and Methotrexate in Relapsed/Refractory Lymphoblastic Leukemia and Lymphoma [Phase 2]
Phase 2 trial evaluating sirolimus and methotrexate in relapsed/refractory lymphoblastic leukemia and lymphoma has completed with results po…
-
CLINICAL_TRIALS trial_result · 2019-07-16Clinical Trial Update: Donor Lymphocyte Infusion (DLI) of T-cells Genetically Modified With iCasp9 Suicide Gene [Phase 1, Phase 2]
Phase 1/2 trial evaluating donor lymphocyte infusion of T-cells genetically modified with an iCasp9 suicide gene for leukemia and myeloma; t…
-
CLINICAL_TRIALS trial_result · 2019-06-25Clinical Trial Update: A Clinical Research of CD20-Targeted CAR-T in B Cell Malignancies [Phase 1, Phase 2]
Early-phase clinical trial update on CD20-targeted CAR-T therapy for B cell malignancies (Phase 1/Phase 2).
-
CLINICAL_TRIALS trial_result · 2019-06-25Clinical Trial Update: A Clinical Research of CD123-Targeted CAR-T in Myeloid Malignancies [Phase 1, Phase 2]
A clinical trial update for a CD123-targeted CAR-T therapy in myeloid malignancies across Phase 1 and Phase 2.
-
CLINICAL_TRIALS trial_result · 2019-06-25Clinical Trial Update: A Clinical Research of CAR T Cells Targeting CD19 Positive Malignant B-cell Derived Leukemia and Lymphoma [Phase 1, Phase 2]
A phase 1/2 clinical trial evaluating CAR T cells targeting CD19 for malignant B-cell leukemia and lymphoma; current status is unknown.
-
CLINICAL_TRIALS trial_result · 2019-06-25Clinical Trial Update: A Clinical Research of CD22-Targeted CAR-T in B Cell Malignancies [Phase 1, Phase 2]
Clinical trial update on CD22-targeted CAR-T for B cell malignancies across Phase 1 and Phase 2.
-
CLINICAL_TRIALS trial_result · 2019-06-25Clinical Trial Update: A Clinical Research of CD30-Targeted CAR-T in Lymphocyte Malignancies [Phase 1, Phase 2]
A clinical trial update regarding CD30-targeted CAR-T therapy in lymphocyte malignancies spanning Phase 1 and Phase 2.
-
CLINICAL_TRIALS trial_result · 2019-05-29Clinical Trial Update: Decitabine Plus mBU/CY Preconditioning for Relapse/Refractory Acute Leukemia [Phase 2, Phase 3]
Clinical trial update on decitabine combined with mBU/CY preconditioning for relapse/refractory acute leukemia in Phase 2/Phase 3.
-
CLINICAL_TRIALS trial_result · 2019-05-20Clinical Trial Update: Safety and Efficacy Evaluation of IM19 CAR-T Cells (IM19CAR-T) [Phase 1, Phase 2]
Phase 1/2 trial update reporting safety and efficacy evaluation for IM19 CAR-T cells in leukemia.
-
CLINICAL_TRIALS trial_result · 2019-05-13Clinical Trial Update: A Study for Patients With Acute Leukemia [Phase 1]
Phase 1 clinical trial update for acute leukemia has been terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2019-05-10Clinical Trial Update: Decitabine Followed by Clofarabine, Idarubicin, and Cytarabine in Acute Leukemia [Phase 1, Phase 2]
A phase 1/2 trial evaluating decitabine followed by clofarabine, idarubicin, and cytarabine in acute leukemia has completed with posted resu…
-
CLINICAL_TRIALS trial_result · 2019-03-27Clinical Trial Update: Double Cord Blood Transplant for Patients With Malignant and Non-malignant Disorders [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating double cord blood transplant for malignant and non-malignant disorders; study terminated with results po…
-
CLINICAL_TRIALS trial_result · 2019-03-14Clinical Trial Update: Safety Study of Bone Marrow Transplant Using Mismatched Tissue Followed by Chemotherapy [Phase 2]
A Phase 2 clinical trial evaluating safety of bone marrow transplant from mismatched tissue followed by chemotherapy in patients with myelod…
-
CLINICAL_TRIALS trial_result · 2019-02-19Clinical Trial Update: Prospective Study on the Feasibility of Plasma FLT3-Ligand Assay to Achieve a First Estimate of Its Prognostic Value on the Outcome of Patients Treated Intensively for Acute Leukemia
A completed prospective study assessing the feasibility of using plasma FLT3-ligand levels to estimate its prognostic value for outcomes in …
-
CLINICAL_TRIALS trial_result · 2019-02-04Clinical Trial Update: Busulfan-fludarabine Conditioning and T-cell Depleted Allogeneic Stem Cell Transplantation for Patients With Advanced Hematologic Malignancies [Phase 1, Phase 2]
This update reports phase 1/2 results for busulfan-fludarabine conditioning followed by T-cell depleted allogeneic stem cell transplantation…